Peter Nicklin

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Peter Nicklin's trades of Hansa Biopharma AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
382.28
Quantity 63,969
Value SEK2,259,750
Transaction date
Purchase
Price
215.14
Quantity 28,408
Value SEK2,491,817
Transaction date
Purchase
Price
95.01
Quantity 98,358
Value SEK2,623,789
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-12 2025-08-05
B Purchase
63,969
382.28
SEK2,259,750 		63,969 382.28 SEK2,259,750
2024-02-08 2024-02-06
B Purchase
28,408
215.14
SEK2,491,817 		28,408 215.14 SEK2,491,817
2022-08-02 2022-07-19
B Purchase
98,358
95.01
SEK2,623,789 		98,358 95.01 SEK2,623,789
2022-07-25 2022-07-19
B Purchase
14,500
71.19
SEK1,032,193 		14,500 71.19 SEK1,032,193